Biolargo Inc
(BLGO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,347 | -4,648 | -5,132 | -6,894 | -9,700 |
| Depreciation Amortization | 255 | 272 | 45 | 20 | 58 |
| Accounts receivable | -569 | -1,633 | -551 | -29 | -142 |
| Other Working Capital | -1,620 | -1,077 | -250 | 249 | 69 |
| Other Operating Activity | 3,075 | 4,721 | 3,126 | 2,717 | 5,561 |
| Operating Cash Flow | $-3,206 | $-2,365 | $-2,762 | $-3,937 | $-4,154 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,235 | -478 | -271 | -21 | -23 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -100 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -13 | N/A |
| Other Investing Activity | -82 | 0 | 0 | -13 | 0 |
| Investing Cash Flow | $-1,317 | $-478 | $-271 | $-34 | $-123 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 100 | -37 | 260 |
| Debt Issued | -14 | 65 | N/A | N/A | N/A |
| Common Stock Issued | 3,588 | 3,046 | 3,657 | 5,096 | 3,634 |
| Other Financing Activity | 864 | 1,548 | 199 | -828 | 446 |
| Financing Cash Flow | $4,438 | $4,659 | $3,956 | $4,231 | $4,340 |
| Exchange Rate Effect | 94 | -128 | -34 | -14 | -2 |
| Beginning Cash Position | 3,539 | 1,851 | 962 | 716 | 655 |
| End Cash Position | 3,548 | 3,539 | 1,851 | 962 | 716 |
| Net Cash Flow | $9 | $1,688 | $889 | $246 | $61 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,206 | -2,365 | -2,762 | -3,937 | -4,154 |
| Capital Expenditure | -1,235 | -478 | -271 | -21 | -23 |
| Free Cash Flow | -4,441 | -2,843 | -3,033 | -3,958 | -4,177 |